Full-Time

Business Development Director

ClinChoice

ClinChoice

1,001-5,000 employees

Global CRO providing full-service clinical development

No salary listed

Germany

In Person

Bachelor's, MBA

Category
Business & Strategy (1)
Required Skills
Sales

Get referred to ClinChoice

See people who can refer or advise you

Requirements
  • 6+ years of sales and account management experience selling
  • Previous experience selling CRO full services (mandatory)
  • Established a network of decision-makers in the life-sciences industry.
  • Experience selling to, presenting to, and building relationships with senior management and C-level stakeholders.
  • Strong negotiation skills with a proven track record of closing complex business deals
  • Persuasive and compelling presentation and communication skills, both written and verbal
  • Ability to interpret business challenges and present quick and responsive high-level solutions.
  • Deadline-driven with a proven ability to manage multiple engagements at varying points in the sales cycle.
  • Positive employer and client references
  • BA, MBA, or equivalent experience
Responsibilities
  • Identify, assess, and pursue new business opportunities.
  • Build and maintain positive relationships and provide regular face time with key decision makers within prospect and client organizations.
  • Develop a deep appreciation for the client's business challenges and organizational structure and use this insight to develop realistic and actionable account plans.
  • Contribute to the ongoing refinement of the company's business development approach, defining client and vertical targets, minimizing the cost of sales, and increasing both efficiencies and closing rates.
  • Work to exceed revenue targets that align with the company's growth objectives.

ClinChoice provides outsourced clinical development services as a global CRO for pharmaceutical, biotechnology, medical device, and consumer health clients. It supports trials across the full lifecycle with services including clinical operations, biostatistics, data management, regulatory affairs, medical affairs, pharmacovigilance, and project management, and it offers project-based or Functional Service Provider (FSP) engagement models. The company differentiates itself through its scale and international reach (4,000+ professionals in 30+ countries) and a track record of 1,500+ full-service studies, aided by growth from mergers and acquisitions. Its goal is to help clients accelerate drug and device approvals by efficiently managing multinational trials and navigating complex regulatory environments throughout development and post-marketing.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Whitemarsh Township, Pennsylvania

Founded

1995

Get referred to ClinChoice

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The March 2026 Monash deal expands access to university-led early-stage programs.
  • Medidata renewal strengthens trial efficiency across Asia, Europe, and North America.
  • Ongoing event presence in Berlin, Lisbon, Barcelona, and Boston signals active business development.

What critics are saying

  • Revelio shows headcount fell to 2,314 in March 2026, and postings dropped 27.8%.
  • ClinChoice’s acquisition-heavy model risks integration drag across CROMSOURCE, CSI, and earlier purchases.
  • IQVIA, ICON, and Labcorp commoditize full-service CRO work; margin pressure can erase independence.

What makes ClinChoice unique

  • ClinChoice spans Asia, Europe, and North America with 4,000 professionals across 30 countries.
  • The March 23, 2026 Monash partnership anchors early-phase trials in Australia.
  • Its 13-year Medidata relationship adds Clinical Data Studio and AI-enabled data management.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

9%

1 year growth

9%

2 year growth

9%
PR Newswire
Jan 12th, 2024
ClinChoice Acquires CSI, Expanding its Global Footprint into Southeast Asia

/PRNewswire/ -- ClinChoice, a leading global Contract Research Organization (CRO), today announced expanding its global footprint with the acquisition of CSI...

TalentSource Life Sciences
Mar 20th, 2023
Outsourcing in Clinical Trials Southeast 2023 – TalentSource Life Sciences

On March 1 st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities.

AVCJ
Jul 6th, 2022
Legend Capital invests into ClinChoice Inc. in $150M

US and China-based clinical contract research organization (CRO) company ClinChoice has raised a USD 150m Series E round led by Legend Capital.

Endpoints News
Jul 5th, 2022
Fountain Medical Development Ltd receives financing of $150M in Series E funding round

ClinChoice, formerly Fountain Medical Development, has completed a $150 million Series E funding round, using the cash to continue its planned expansion.

The HealthCo
Apr 13th, 2022
Cloudbyz, Inc. partnered with ClinChoice Inc. on Apr 13th 22'.

Cloudbyz, a fast-growing integrated clinical research and development solution provider with integrated capabilities, today announced a partnership with ClinChoice, a global full-service clinical CRO dedicated to offering high-quality one-stop service to biopharmaceutical, Vaccine, Medical Device, Cosmetics, Nutraceuticals, and Consumer Products clients.